Clinical operations produce the documents a submission depends on — protocols, amendments, investigator’s brochures, clinical study reports. Regulatory needs them, in their final form, on a deadline. In most companies the two systems that hold them barely talk.
Key takeaways
- eTMF and RIM hold many of the same documents for different purposes.
- Without a connection, the hand-off runs on email, downloads and “final final” versions.
- The integration is easy compared with agreeing ownership, definitions and triggers.
- Start with the document that hurts most — usually the clinical study report.
One of the most persistent gaps in drug development sits between clinical operations and regulatory affairs — and between the systems each relies on. Clinical teams manage the foundational documents of a trial in the eTMF, through review, approval and quality checks. Regulatory teams plan submissions in RIM and need many of those same documents to build compliant packages.
In most organisations the documents do not flow from one to the other. They move by email attachment, shared drive and urgent request, and the result is duplication, version confusion and delay — most visibly when Regulatory discovers it has been working from an outdated draft because nothing told it the final version was ready.
What the gap costs
Regulatory relies on emails and spreadsheets to know the status of clinical documents. Documents are downloaded from the eTMF, uploaded to RIM or a shared drive, renamed and edited, so it is no longer clear which version is authoritative or which one went into the last submission. Documents already quality-checked in one system are re-uploaded and re-governed in the other. And without visibility into the clinical pipeline, Regulatory cannot forecast readiness until a problem is already late.
The integration is the easy part. Agreeing what “final” means is the hard part.
More than an integration
Connecting the two systems is a technical task with a well-understood shape. The harder work is agreeing who owns each document type, which system is the record of truth for it, what “final” and “ready for submission” mean, and what event triggers the hand-off. Without those agreements, an integration just moves the confusion faster.
Where to start
Start with the document that causes the most pain — usually the clinical study report. Define when it is final, who confirms it, and how RIM learns that it is available for the planned sequence. Prove the flow for that one document type, then extend it to protocols, amendments and investigator’s brochures.
How DnXT helps
DnXT’s Veeva Vault advisory team works across RIM and the systems around it — including the Quality–Regulatory connection and content planning — with the governance and process work that makes integrations hold.
Connect clinical and regulatory
Talk to DnXT’s Vault advisory team about the hand-offs that slow your submissions down.